 REDWOOD CITY, Calif., Feb. 16, 2021 GLOBE NEWSWIRE -- Pulmonx Corporation Nasdaq: LUNG Pulmonx, a global leader in minimally invasive treatments for lung disease, today announced that it will release financial results for the fourth quarter and full year of 2020 after the close of trading on Tuesday, March 2, 2021. Company management will host a conference call to discuss financial results beginning at 1:30 p.m. PT 4:30 p.m. ET. 